Select Page

Table 12.19 Effects of Haloperidol on Agitation

Author Year

Country

Research Design

PEDro

Sample Size

 

Methods

 

Outcomes

Rao et al. (1985)

USA

Case Series

N=26

 

Population: Severe TBI; Age Range=16-48 yr.

Treatment: Retrospective review of individuals whose agitation was treated with haloperidol (n=11; 2-15 mg/day) and those who were not (n=15).

Outcome Measure: Patient Evaluation Conference Systems.

1.       Those treated had a longer length of PTA (p<0.03).

2.       No statistically significant differences were shown between those who were and were not treated in terms of independent living at discharge (64% versus 60%, respectively) or independence in managing behaviour (40% versus 60%).

3.       3 of those non treated obtained independence in intellectual skills but none of the treated patients did this.